[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f9QZcv4Av2R7ebzrH6pUDWdNAqmMRuNxPBb7oEO1Ebx8":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":31,"phaseBuckets":37,"rows":44},"Cantonal Hospital of St. Gallen",[4],76,false,6,3,444875,1,63,[14,16,19,21,23,25,27,29],{"name":15,"count":9},"Fecal Incontinence",{"name":17,"count":18},"Thyroidectomy",2,{"name":20,"count":18},"Rectal Cancer",{"name":22,"count":18},"Functional Outcome",{"name":24,"count":18},"Surgery",{"name":26,"count":18},"HIV Infections",{"name":28,"count":18},"Inguinal Hernia",{"name":30,"count":18},"Multiple Sclerosis",[32],{"nctId":33,"briefTitle":34,"date":35,"intervention":36},"NCT06279000","Colchicine in Patients at Cardiac Risk Undergoing Major Non-Cardiac Surgery","2028-03-30","Colchicine",[38,39,40,41,42,43],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[45,73,102,130,156,174,200,223,249,275,301,325,350,376],{"intervention":36,"totalTrials":11,"cells":46},{"EARLY_PHASE1":47,"PHASE1":50,"PHASE2":52,"PHASE3":54,"PHASE4":69,"NA":71},{"trials":48,"activeCount":49},[],0,{"trials":51,"activeCount":49},[],{"trials":53,"activeCount":49},[],{"trials":55,"activeCount":11,"soonestReadout":35},[56],{"nctId":33,"briefTitle":34,"status":57,"phases":58,"primaryCompletion":35,"completion":59,"start":60,"enrollment":61,"conditions":62,"interventions":68},"RECRUITING",[41],"2029-03-30","2025-04-20",880,[63,64,65,66,67],"Cardiovascular Diseases","Cardiovascular Complication","Perioperative Complication","Myocardial Injury","Myocardial Injury After Noncardiac Surgery (MINS)",[36],{"trials":70,"activeCount":49},[],{"trials":72,"activeCount":49},[],{"intervention":74,"totalTrials":11,"cells":75},"Neviparine",{"EARLY_PHASE1":76,"PHASE1":78,"PHASE2":80,"PHASE3":82,"PHASE4":84,"NA":100},{"trials":77,"activeCount":49},[],{"trials":79,"activeCount":49},[],{"trials":81,"activeCount":49},[],{"trials":83,"activeCount":49},[],{"trials":85,"activeCount":49},[86],{"nctId":87,"briefTitle":88,"status":89,"phases":90,"primaryCompletion":91,"completion":92,"start":93,"enrollment":94,"conditions":95,"interventions":99},"NCT07014189","Nevirapine \u002F Lamivudine for HIV Maintenance Therapy","COMPLETED",[42],"2023-01-10","2023-08-31","2019-04-12",201,[96,97,98],"HIV Infection","Antiretroviral Treatment","Maintenance Therapy",[74],{"trials":101,"activeCount":49},[],{"intervention":103,"totalTrials":11,"cells":104},"Phenprocoumon",{"EARLY_PHASE1":105,"PHASE1":107,"PHASE2":109,"PHASE3":111,"PHASE4":113,"NA":128},{"trials":106,"activeCount":49},[],{"trials":108,"activeCount":49},[],{"trials":110,"activeCount":49},[],{"trials":112,"activeCount":49},[],{"trials":114,"activeCount":49},[115],{"nctId":116,"briefTitle":117,"status":89,"phases":118,"primaryCompletion":119,"completion":119,"start":120,"enrollment":121,"conditions":122,"interventions":127},"NCT00586287","Study to Find Out the Appropriate Initial Dose of the Anticoagulant Drug Phenprocoumon",[42],"2011-12","2007-01",302,[123,124,125,126],"Pulmonary Embolism","Atrial Fibrillation","Hip Replacement Postoperative","Knee Replacement Postoperative",[103],{"trials":129,"activeCount":49},[],{"intervention":131,"totalTrials":11,"cells":132},"Lopinavir-Monotherapy",{"EARLY_PHASE1":133,"PHASE1":135,"PHASE2":137,"PHASE3":139,"PHASE4":141,"NA":154},{"trials":134,"activeCount":49},[],{"trials":136,"activeCount":49},[],{"trials":138,"activeCount":49},[],{"trials":140,"activeCount":49},[],{"trials":142,"activeCount":49},[143],{"nctId":144,"briefTitle":145,"status":146,"phases":147,"primaryCompletion":148,"completion":149,"start":120,"enrollment":150,"conditions":151,"interventions":152},"NCT00531986","HIV - Monotherapy in Switzerland (MOST-ch)","TERMINATED",[42],"2008-09","2008-12",60,[26],[131,153],"HAART",{"trials":155,"activeCount":49},[],{"intervention":153,"totalTrials":11,"cells":157},{"EARLY_PHASE1":158,"PHASE1":160,"PHASE2":162,"PHASE3":164,"PHASE4":166,"NA":172},{"trials":159,"activeCount":49},[],{"trials":161,"activeCount":49},[],{"trials":163,"activeCount":49},[],{"trials":165,"activeCount":49},[],{"trials":167,"activeCount":49},[168],{"nctId":144,"briefTitle":145,"status":146,"phases":169,"primaryCompletion":148,"completion":149,"start":120,"enrollment":150,"conditions":170,"interventions":171},[42],[26],[131,153],{"trials":173,"activeCount":49},[],{"intervention":175,"totalTrials":11,"cells":176},"Dexamethasone",{"EARLY_PHASE1":177,"PHASE1":179,"PHASE2":181,"PHASE3":183,"PHASE4":196,"NA":198},{"trials":178,"activeCount":49},[],{"trials":180,"activeCount":49},[],{"trials":182,"activeCount":49},[],{"trials":184,"activeCount":49},[185],{"nctId":186,"briefTitle":187,"status":89,"phases":188,"primaryCompletion":189,"completion":190,"start":191,"enrollment":192,"conditions":193,"interventions":195},"NCT01189292","Preoperative Single-dose Steroid Application for the Treatment of Nausea and Vomiting After Thyroid Surgery",[41],"2013-05","2013-06","2011-01",152,[17,194],"Thyroid Diseases",[175],{"trials":197,"activeCount":49},[],{"trials":199,"activeCount":49},[],{"intervention":201,"totalTrials":11,"cells":202},"bilateral superficial cervical block",{"EARLY_PHASE1":203,"PHASE1":205,"PHASE2":207,"PHASE3":209,"PHASE4":219,"NA":221},{"trials":204,"activeCount":49},[],{"trials":206,"activeCount":49},[],{"trials":208,"activeCount":49},[],{"trials":210,"activeCount":49},[211],{"nctId":212,"briefTitle":213,"status":89,"phases":214,"primaryCompletion":149,"completion":149,"start":215,"enrollment":216,"conditions":217,"interventions":218},"NCT00472446","Superficial, Cervical Block in Thyroid Surgery, a Randomized Controlled Trial",[40,41],"2006-01",183,[17],[201],{"trials":220,"activeCount":49},[],{"trials":222,"activeCount":49},[],{"intervention":224,"totalTrials":11,"cells":225},"lamotrigine",{"EARLY_PHASE1":226,"PHASE1":228,"PHASE2":230,"PHASE3":243,"PHASE4":245,"NA":247},{"trials":227,"activeCount":49},[],{"trials":229,"activeCount":49},[],{"trials":231,"activeCount":49},[232],{"nctId":233,"briefTitle":234,"status":235,"phases":236,"primaryCompletion":237,"completion":119,"start":238,"enrollment":239,"conditions":240,"interventions":242},"NCT00917839","The Neuroprotective Effect of Lamotrigine and Interferon Beta 1a in Patients With Relapsing-Remitting Multiple Sclerosis","UNKNOWN",[40],"2010-12","2009-06",88,[241],"Relapsing-Remitting Multiple Sclerosis",[224],{"trials":244,"activeCount":49},[],{"trials":246,"activeCount":49},[],{"trials":248,"activeCount":49},[],{"intervention":250,"totalTrials":11,"cells":251},"Dendritic cell application",{"EARLY_PHASE1":252,"PHASE1":254,"PHASE2":256,"PHASE3":269,"PHASE4":271,"NA":273},{"trials":253,"activeCount":49},[],{"trials":255,"activeCount":49},[],{"trials":257,"activeCount":49},[258],{"nctId":259,"briefTitle":260,"status":89,"phases":261,"primaryCompletion":262,"completion":263,"start":264,"enrollment":265,"conditions":266,"interventions":268},"NCT01897207","Phase I\u002FII Study of Vaccination With Antigen Loaded Dendritic Cells (DCs) in Hormone-Refractory Prostate Cancer",[39,40],"2009-08","2011-10","2002-11",15,[267],"Cancer of the Prostate",[250],{"trials":270,"activeCount":49},[],{"trials":272,"activeCount":49},[],{"trials":274,"activeCount":49},[],{"intervention":276,"totalTrials":11,"cells":277},"Radioactive labelling of pulmonary nodules",{"EARLY_PHASE1":278,"PHASE1":280,"PHASE2":282,"PHASE3":295,"PHASE4":297,"NA":299},{"trials":279,"activeCount":49},[],{"trials":281,"activeCount":49},[],{"trials":283,"activeCount":49},[284],{"nctId":285,"briefTitle":286,"status":146,"phases":287,"primaryCompletion":288,"completion":288,"start":289,"enrollment":290,"conditions":291,"interventions":294},"NCT02050724","ThoHSpEkt Thoracoscopic Ectomy of Radioactively Marked Pulmonary Nodules With Free-hand SPECT",[40],"2016-12-31","2013-11",11,[292,293],"Solitary Pulmonary Nodule","Bronchial Neoplasms",[276],{"trials":296,"activeCount":49},[],{"trials":298,"activeCount":49},[],{"trials":300,"activeCount":49},[],{"intervention":302,"totalTrials":11,"cells":303},"ghrelin",{"EARLY_PHASE1":304,"PHASE1":306,"PHASE2":308,"PHASE3":319,"PHASE4":321,"NA":323},{"trials":305,"activeCount":49},[],{"trials":307,"activeCount":49},[],{"trials":309,"activeCount":49},[310],{"nctId":311,"briefTitle":312,"status":89,"phases":313,"primaryCompletion":119,"completion":119,"start":238,"enrollment":314,"conditions":315,"interventions":318},"NCT00933361","Individual Dose-escalated Bi-daily Subcutaneously (sc) Ghrelin in Cancer Cachexia: a Phase I\u002FII Study",[39,40],21,[316,317],"Advanced Cancer","Cachexia",[302],{"trials":320,"activeCount":49},[],{"trials":322,"activeCount":49},[],{"trials":324,"activeCount":49},[],{"intervention":326,"totalTrials":11,"cells":327},"Bendamustine",{"EARLY_PHASE1":328,"PHASE1":330,"PHASE2":332,"PHASE3":344,"PHASE4":346,"NA":348},{"trials":329,"activeCount":49},[],{"trials":331,"activeCount":49},[],{"trials":333,"activeCount":49},[334],{"nctId":335,"briefTitle":336,"status":89,"phases":337,"primaryCompletion":338,"completion":338,"start":339,"enrollment":340,"conditions":341,"interventions":343},"NCT01701076","Bendamustine, Lenalidomide (Revlimid®) and Dexamethasone (BRd) as 2nd-line Therapy for Patients With Relapsed or Refractory Multiple Myeloma",[40],"2016-02","2012-03",50,[342],"Multiple Myeloma",[326],{"trials":345,"activeCount":49},[],{"trials":347,"activeCount":49},[],{"trials":349,"activeCount":49},[],{"intervention":351,"totalTrials":11,"cells":352},"Dronabinol",{"EARLY_PHASE1":353,"PHASE1":355,"PHASE2":357,"PHASE3":359,"PHASE4":361,"NA":363},{"trials":354,"activeCount":49},[],{"trials":356,"activeCount":49},[],{"trials":358,"activeCount":49},[],{"trials":360,"activeCount":49},[],{"trials":362,"activeCount":49},[],{"trials":364,"activeCount":49},[365],{"nctId":366,"briefTitle":367,"status":89,"phases":368,"primaryCompletion":369,"completion":369,"start":370,"enrollment":371,"conditions":372,"interventions":375},"NCT00812851","Randomized Placebo-Controlled Crossover Trial With THC (Delta 9-Tetrahydrocannabinol) for the Treatment of Cramps in Amyotrophic Lateral Sclerosis (ALS)",[43],"2008-04","2005-04",24,[373,374],"Cramps","Amyotrophic Lateral Sclerosis",[351],{"intervention":377,"totalTrials":11,"cells":378},"Cisplatin",{"EARLY_PHASE1":379,"PHASE1":381,"PHASE2":383,"PHASE3":385,"PHASE4":387,"NA":389},{"trials":380,"activeCount":49},[],{"trials":382,"activeCount":49},[],{"trials":384,"activeCount":49},[],{"trials":386,"activeCount":49},[],{"trials":388,"activeCount":49},[],{"trials":390,"activeCount":49},[391],{"nctId":392,"briefTitle":393,"status":146,"phases":394,"primaryCompletion":119,"completion":395,"start":396,"enrollment":8,"conditions":397,"interventions":400},"NCT00968799","Hyperthermic Intraoperative Intraperitoneal Chemotherapy of Recurrent Ovarian Cancer - A Feasibility Study",[43],"2012-12","2008-02",[398,399],"Epithelial Ovarian Cancer","Fallopian Tube Carcinoma",[377]]